Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

34 trials with published results (7%)

Research Maturity

337 completed trials (67% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.1%

31 terminated out of 506 trials

Success Rate

91.6%

+5.0% vs benchmark

Late-Stage Pipeline

12%

63 trials in Phase 3/4

Results Transparency

10%

34 of 337 completed with results

Key Signals

34 with results92% success31 terminated

Data Visualizations

Phase Distribution

267Total
Not Applicable (142)
Early P 1 (1)
P 1 (26)
P 2 (35)
P 3 (51)
P 4 (12)

Trial Status

Completed337
Unknown60
Recruiting37
Terminated31
Withdrawn14
Active Not Recruiting13

Trial Success Rate

91.6%

Benchmark: 86.5%

Based on 337 completed trials

Clinical Trials (506)

Showing 20 of 20 trials
NCT07552779Phase 1Completed

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

NCT04776447Phase 2CompletedPrimary

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

NCT06177717RecruitingPrimary

Deep Functional Phenotyping of the ALA Lung Health Cohort

NCT06728709Completed

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

NCT06925373Not ApplicableRecruitingPrimary

Housing, Environment, And Living Conditions for Transformed Health

NCT04365101Phase 1Terminated

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

NCT03250897CompletedPrimary

Phenotypic Characterization of Alveolar Macrophages 2016 (Caract-Aires-2016)

NCT03626688Phase 3Completed

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT07646015Completed

Validate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic Disorders

NCT05798286Not ApplicableCompletedPrimary

Quantra® System With the QPlus® Cartridge in Double-lung Transplantation

NCT05922761Phase 2Recruiting

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

NCT06494241Active Not Recruiting

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

NCT07360522Active Not RecruitingPrimary

Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting

NCT07227376RecruitingPrimary

Data Collection Using Eko Digital Devices in a Clinical Setting

NCT04263038Phase 4Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT06376084Active Not Recruiting

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

NCT05279040Recruiting

Trikafta Exercise Study in Cystic Fibrosis

NCT06431633Phase 3RecruitingPrimary

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

NCT03522831Not ApplicableActive Not RecruitingPrimary

CF Bronchodilation

NCT07567950Not ApplicableNot Yet Recruiting

Revised-Paravertebral Nerve Blocks for Enhanced Recovery After Video-assisted Thoracoscopic Pneumonectomy

Scroll to load more

Research Network

Activity Timeline